Norepinephrine Bitartrate in 0.9% Sodium Chloride - (16 mg/250 mL ; Injection)

Generic Name	Norepinephrine Bitartrate in 0.9% Sodium Chloride	Innovator	INFORLIFE
Dosage	16 mg/250 mL ; Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	Norepinephrine Bitartrate in Sodium Chloride Injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****** ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events